US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.56

0.0000

Volume:69

Turnover:2.35K

Market Cap:13.42M

PE:- -

High:33.56

Open:33.56

Low:33.56

Close:33.56

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.13

T/O Rate:0.02%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

DataMEDS AI acquires Helomics subsidiary from Axe Compute for $1.5M

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Gilead announces agreement with PAHO for lenacapavir access

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Johnson & Johnson Says Subcutaneous Cancer Treatment Study Shows Low Rates Across Key Events, Discontinuation

MT Newswires Live

Barclays downgrades Scholar Rock on valuation after FDA approval

Jiangsu Hengrui Secures Green Light for HRS-4139 Tablet Clinical Trials

Huangjia Ruangan Granules Receives Approval for Phase III Clinical Trial in Chronic Hepatitis B Fibrosis Treatment

Shenyang Xingqi Pharma Gains NMPA Approval to Initiate Clinical Trials for SQ-25012 Injection in Thyroid Eye Disease

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BMED/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.5609,"timestamp":1789657525735,"preClose":33.5609,"halted":0,"volume":69,"delay":0,"changeRate":0,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-17 15:18:30 EDT","open":33.5609,"high":33.5609,"low":33.5609,"amount":2349.444687,"amplitude":0,"askPrice":34.15,"askSize":1000,"bidPrice":34.07,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":33.5609,"sharesOutstanding":360000,"nav":33.339378,"aum":13335751.2,"dividendRate":0.002375,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.41,"preClose":33.5609,"latestTime":"16:10 EDT","volume":6,"amount":201.3654,"timestamp":1789589403907,"change":-0.1509,"changeRate":-0.004496,"amplitude":0},"volumeRatio":0.133725,"impliedVol":0.0628,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.133725,"shares":400000,"dividePrice":0.0797,"high":33.5609,"amplitude":0,"preClose":33.5609,"low":33.5609,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.5609,"eps":0,"divideRate":0.002375,"volume":69,"delay":0,"ttmEps":0,"open":33.5609,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":32.8027,"twentyDayClose":34.7939,"sixtyDayClose":28.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667242596","title":"DataMEDS AI acquires Helomics subsidiary from Axe Compute for $1.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2667242596","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667242596?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:15","pubTimestamp":1789503345,"startTime":"0","endTime":"0","summary":"DataMEDS AI (MEDS) announced that it completed the acquisition of artificial intelligence cancer diagnostics laboratory business Helomics from Axe ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/datameds-ai-acquires-helomics-subsidiary-from-axe-compute-for-1-5m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/datameds-ai-acquires-helomics-subsidiary-from-axe-compute-for-1-5m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PJFG","QQA","LCG","AIPO","EGUS","KOMP","ARTY","QTAP","DYNI","AIFD","LCLG","BELT","FWD","AGIX","ANEW","QCAP","CHAT","NSEP","GK","QQQT","AIBU","QQQA","LSGR","MVPS","MEDS","DARP","BMED","MAGQ","BERZ","FELG","VTHR","QSWN","TCAF","TARK","BKIV","NFEB","QQQP","FNGO","AMZY","GQQQ","QTOC","SPXV","FLCG","ONEQ","PQAP","NBDS","FRTY","FDGR","QQH","QGRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667906621","title":"Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier","url":"https://stock-news.laohu8.com/highlight/detail?id=2667906621","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667906621?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:51","pubTimestamp":1789498275,"startTime":"0","endTime":"0","summary":"Health Rounds: New dye for MRI exams detects lung cancer earlierSept 15 -Hello Health Rounds readers!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","JNJ","LU2403377893.USD","LU0058720904.USD","IHE","LU0985320562.USD","LU1674673691.USD","LU2430703178.SGD","PJP","BK4585","LU0432979614.USD","LU0820561818.USD","LU0472753341.HKD","LU1244550221.USD","LU2023250330.USD","BK4504","LU2129689605.HKD","VHT","FHLC","BMED","LU1674673428.USD","LU2592432038.USD","IXJ","SG9999001176.SGD","LU1162221912.USD","IE00B3T34201.USD","IE000BZT7R73.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0072461881.USD","LU0122379950.USD","LU1043141123.HKD","FTXH","JDOC","TRUH","XLV","RXL","IE00BBT3K403.USD","LU1929549753.HKD","IYH","IE00BVYPNW00.USD","LU2602419157.SGD","BK4533","MEDX","LU0889566641.SGD","SG9999002224.SGD","BK4532","LU2430703095.HKD","LU1430594728.SGD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["LABU","TECB","FRTY","IEIH","GNMX","SYNB","GDOC","BK4588","IDNA","TBXU","RSPH","BBP","MRNX","PINK","IBB","PSCH","MRNY","MEDI","NVIB","IYH","BK4585","BMED","XLVX","LFSC","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667490625","title":"Gilead Sciences Expands Lenacapavir Access to 14 Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2667490625","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667490625?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:43","pubTimestamp":1789487029,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Tuesday it entered into an agreement with the Pan American Health Organization to expand access to twice-yearly lenacapavir as pre-exposure prophylaxis for HIV prevention.The agreement creates a new access pathway for 14 PAHO member states in Latin America and the Caribbean outside existing voluntary licensing agreements, complementing generic access efforts across the region, the company said.The countries are Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Mexico, Panama, Paraguay, Peru, Uruguay and Venezuela, Gilead said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIB","LU1674673691.USD","LU0965508806.USD","LU1934455277.USD","BK4585","LU1934455863.HKD","LU0965509283.SGD","IE0002270589.USD","BMED","SG9999015952.SGD","LU1037948897.HKD","LU1430594728.SGD","MEDI","IBB","BK4568","LU0234570918.USD","LU0859254822.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","TBXU","BK4566","LU0114720955.EUR","LU0882574055.USD","BK4588","SG9999015986.USD","BBH","LU2324357040.USD","LU1839511570.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","IE00BKVL7J92.USD","LU0861579265.USD","IBBQ","LU0109394709.USD","GILD","LU0320765992.SGD","LU1571399168.USD","TMED","LU1023059063.AUD","LU0965509010.AUD","LU0823416689.USD","BK4550","LU2112291526.USD","LU0058720904.USD","LU1037948541.HKD","LU0122379950.USD","LU1061106388.HKD","IE00B19Z3581.USD","LU1674673428.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862533","title":"As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862533?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:16","pubTimestamp":1789485372,"startTime":"0","endTime":"0","summary":"The strongest evidence for use of the drugs so far has come from trials in patients with severe depression or post-traumatic stress disorder who have not responded to existing treatments.Early-stage trials are also testing psychedelic drugs for substance abuse disorders, borderline personality disorder, obsessive-compulsive disorders, anxiety, self-harm behavior, chronic Lyme disease and fibromyalgia.HOW DO PSYCHEDELIC TREATMENTS WORK?Psychedelic treatments work primarily by activating proteins on the surface of nerve cells that regulate the brain's ability to reorganize, form new connections, and repair damaged circuits. Unlike traditional psychiatric drugs that may be taken at home on a daily basis, these treatments are usually administered by medical personnel in a limited number of sessions to supplement intensive psychotherapy.WHAT PSYCHEDELIC DRUGS ARE CURRENTLY AUTHORIZED FOR USE?In the U.S. and Europe, the leading candidate for authorization is psilocybin, the active ingredient","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","IE00B19Z3581.USD","IE00B42XCP33.USD","BK4581","IE0009355771.USD","LU2471134523.USD","IE000F7OJYX1.SGD","LU2129689514.USD","IE00BGHQF631.EUR","SG9999001176.SGD","LU1629891620.HKD","SGXZ80539844.SGD","LU0689472784.USD","LU1935042991.SGD","SG9999002224.SGD","IE000WAW04H5.SGD","IE00B1BXHZ80.USD","IE00BDGV0183.EUR","LU0964807845.USD","VHT","CMPS","LU1145028129.USD","LU1291159041.SGD","LU0943347566.SGD","FHLC","LU2471134796.USD","LU0472753341.HKD","LU2236285917.USD","LU2430703095.HKD","LU0345769631.USD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","LU2129689431.USD","LU1043141396.HKD","IE00BLSP4239.USD","LU1057294990.SGD","LU1066051498.USD","LU0426412945.USD","LU0889566641.SGD","LU2430703178.SGD","LU0058720904.USD","LU0426417589.USD","BMED","LU0787776722.HKD","IE00BN8TJ469.HKD","LU1585245621.USD","LU1244550494.USD","BK4504","LU0114720955.EUR","LU0345769128.USD","IE0000B7K699.USD","LU2133065610.SGD","LU1244550221.USD","LU0289739699.SGD","MEDX","LU2487616109.SGD","LU2505996509.AUD","LU0053666078.USD","SGXZ57979304.SGD","LU0289961442.SGD","LU2505996681.GBP","LU1196500208.SGD","IE0002141913.USD","JDOC","LU0795875169.SGD","LU1032955483.USD","LU0057025933.USD","LU1162221912.USD","LU0820561818.USD","LU0345770993.USD","LU1894683264.USD","LU2750360641.GBP","XLV","LU0640476718.USD","LU1778281490.HKD","LU1221951129.SGD","LU2756315664.SGD","LU2756315318.SGD","LU2112291526.USD","LU1066051811.HKD","LU0070217475.USD","LU0912757837.SGD","LU1732799900.SGD","BK4559","GDOC","LU2347655156.SGD","LU1261432733.SGD","LU0511384066.AUD","SG9999001440.SGD","LU0820562030.AUD","LU0882574055.USD","IE00BLSP4452.SGD","LU1989771016.USD","LU0820561909.HKD","LU0234570918.USD","LU2430703251.USD","LU2471134952.CNY","IE000MB6IJN5.SGD","IE00BJT1NW94.SGD","IE0002270589.USD","LU1551013425.SGD","RXL","IE000BZT7R73.USD","BK4588","LU0289739343.SGD","LU1674673428.USD","LU0162691827.USD","IXJ","LU1894683348.USD","LU1674673691.USD","LU1043141123.HKD","LU0210536198.USD","LU1228905037.USD","LU2417539215.USD","LU2471134879.HKD","LU2750360997.AUD","PJP","LU0320765646.SGD","LU1506573853.SGD","IE00BSNM7G36.USD","LU1718418525.SGD","IE00BFXG1179.USD","LU0203347892.USD","JNJ","LU1032466523.USD","BK4592","LU1732800096.USD","PBM","LU2468319806.SGD","BK4007","LU0124676726.USD","IE00BZ1G4Q59.USD","LU1061106388.HKD","IE00BVYPNW00.USD","BK4533","LU0792757196.USD","LU1074936037.SGD","BK4534","LU2592432038.USD","LU0545562505.USD","LU1267930813.SGD","LU0689626769.HKD","IE0001KFT4U8.USD","BK4585","BK4550","LU2089984988.USD","LU0122379950.USD","PSIL","LU1059921491.USD","TRUH","LU2403377893.USD","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","LU1496350502.SGD","LU2456880835.USD","BK4532","LU0203345920.USD","IE0034235303.USD","LU1228905540.USD","IE000SO60NU8.SGD","LU1066053197.SGD","LU0994945656.USD","LU1914381329.SGD","LU1430594728.SGD","LU0432979614.USD","LU0072461881.USD","IE00B7SZLL34.SGD","LU2129689605.HKD","LU0985320562.USD","LU2023250330.USD","LU2602419157.SGD","IE00BBT3K403.USD","IHE","LU2896262040.SGD","LU0466842654.USD","LU1066051225.USD","SG9999001176.USD","LU1221951046.USD","IE00B4R5TH58.HKD","LU0795875086.SGD","IE00BKVL7J92.USD","LU0234572021.USD","LU2213496289.HKD","IE00B2B36J28.USD","LU1983299246.USD","LU1023059063.AUD","LU0098860793.USD","LU0683600562.USD","LU0069063385.USD","FTXH","IE00BJJMRZ35.SGD","BK4139","BK4568","IE000M9KFDE8.USD","IE00B3T34201.USD","SG9999013999.USD","LU0210528500.USD","IE00B3PB1722.GBP","LU1244550577.SGD","LU1121112475.USD","LU1929549753.HKD","IYH","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625575","title":"Gilead announces agreement with PAHO for lenacapavir access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625575","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625575?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485318,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced a new agreement with the Pan American Health Organization, or PAHO, to accelerate access to twice-yearly lenacapav...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-announces-agreement-with-paho-for-lenacapavir-access-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IBB","LU0965509101.SGD","LU1778281490.HKD","LU2089984988.USD","TMED","LU1839511570.USD","LU0965509010.AUD","TBXU","MEDI","BK4550","LU1066051498.USD","BK4578","SG9999015986.USD","LU1585245621.USD","LU1430594728.SGD","LU0234570918.USD","LU1934455863.HKD","SG9999015952.SGD","LU1571399168.USD","BK4583","BK4585","GILD","LU0965509283.SGD","BK4566","LU0882574055.USD","LU1674673428.USD","BMED","LU0861579265.USD","BK4588","LU1023059063.AUD","LU1674673691.USD","LU2324357040.USD","LU1037948541.HKD","IBBQ","LU0859254822.USD","IE0002270589.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4568","LU1061106388.HKD","LU1066053197.SGD","BK4532","SG9999015945.SGD","IE00B7SZLL34.SGD","LU1037948897.HKD","BIB","LU2468319806.SGD","LU0114720955.EUR","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623063","title":"Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623063","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623063?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","LU1061106388.HKD","LU0965509010.AUD","LU0965509283.SGD","BK4578","IE0002270589.USD","GILD","BMED","IE00B19Z3581.USD","TMED","LU1778281490.HKD","LU1037948897.HKD","LU0234570918.USD","LU0859254822.USD","LU1839511570.USD","BK4532","IBB","IE00BKVL7J92.USD","SG9999015986.USD","IE00B3T34201.USD","MEDI","LU0058720904.USD","LU1057294990.SGD","LU0889565916.HKD","LU1066053197.SGD","LU2324357040.USD","LU1571399168.USD","LU2468319806.SGD","BBH","IBBQ","LU1674673691.USD","LU0861579265.USD","BK4566","BIB","LU0109394709.USD","LU1430594728.SGD","SG9999015952.SGD","LU1037948541.HKD","LU0823416689.USD","LU1934455277.USD","TBXU","LU1585245621.USD","LU2357627491.SGD","LU0882574055.USD","SG9999015945.SGD","SG9999015978.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","BK4583","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623061","title":"Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623061","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623061?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0859254822.USD","IE0002270589.USD","TBXU","BK4550","LU1057294990.SGD","LU1066051498.USD","SG9999015945.SGD","IBBQ","LU0965509283.SGD","LU0122379950.USD","LU1571399168.USD","LU1934455277.USD","BK4532","LU2324357040.USD","LU1934455194.USD","LU0289739699.SGD","BMED","LU1778281490.HKD","BK4566","IBB","BK4568","LU0965509101.SGD","LU2089984988.USD","BIB","LU1066053197.SGD","BK4578","BK4139","GILD","LU0109394709.USD","LU1037948897.HKD","IE00B3T34201.USD","BK4585","LU0058720904.USD","LU2357627491.SGD","LU2468319806.SGD","TMED","LU0114720955.EUR","SG9999015952.SGD","LU1061106388.HKD","LU0965508806.USD","LU1037948541.HKD","LU0965509010.AUD","BK4588","SG9999015986.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","MEDI","BBH","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667237756","title":"Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667237756","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667237756?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMED","LU2089984988.USD","LU1934455277.USD","BK4568","IE00BZ1G4Q59.USD","LU0109394709.USD","BK4566","LU1778281490.HKD","LU1057294990.SGD","LU0859254822.USD","BK4550","LU0965508806.USD","LU0965509283.SGD","LU1061106388.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","BK4583","LU0289739699.SGD","LU0882574055.USD","LU0965509101.SGD","BK4585","LU0058720904.USD","LU1674673428.USD","IE00BKVL7J92.USD","BIB","TMED","SG9999015945.SGD","GILD","LU1037948541.HKD","SG9999015978.USD","LU1674673691.USD","BK4532","IBB","LU2468319806.SGD","BK4578","SG9999015952.SGD","TBXU","BK4588","BBH","LU1585245621.USD","LU0861579265.USD","LU1839511570.USD","LU1934455194.USD","MEDI","IBBQ","LU2357627491.SGD","IE00B19Z3581.USD","SG9999015986.USD","IE0002270589.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230916","title":"Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230916?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":"Gilead, PAHO agree on HIV prevention drug access in Latin America, CaribbeanSept 15 (Reuters)-U.S. drugmaker Gilead SciencesGILD.Osaid on Tuesday it had reached an agreement with the Pan American Heal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1037948541.HKD","LU0823416689.USD","SG9999015978.USD","LU0889565916.HKD","BK4578","SG9999015945.SGD","LU0122379950.USD","SG9999015986.USD","LU2112291526.USD","LU1839511570.USD","BK4568","LU1778281490.HKD","LU2089984988.USD","IE00BKVL7J92.USD","LU0109394709.USD","BIB","BK4585","BMED","IE00BSNM7G36.USD","IE0002270589.USD","LU1674673428.USD","LU0965509010.AUD","TBXU","LU2357627491.SGD","LU2324357040.USD","LU1934455863.HKD","TMED","LU0320765992.SGD","IE00B7SZLL34.SGD","IBB","LU1066053197.SGD","LU1571399168.USD","LU1023059063.AUD","BK4532","BK4139","IE00B19Z3581.USD","LU0114720955.EUR","LU1037948897.HKD","LU1430594728.SGD","LU1674673691.USD","IBBQ","LU0289739699.SGD","BBH","MEDI","BK4583","BK4566","GILD","LU0234570918.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230686","title":"Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230686","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230686?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nP8N3M60G8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMED","IE00B7SZLL34.SGD","LU1430594728.SGD","BK4568","LU1571399168.USD","LU1778281490.HKD","IE0002270589.USD","LU1934455863.HKD","LU0234570918.USD","LU0861579265.USD","LU1037948541.HKD","LU2089984988.USD","GILD","BMED","BK4585","LU0289739699.SGD","TBXU","BK4578","LU0859254822.USD","BK4588","IBB","SG9999015945.SGD","LU2468319806.SGD","LU1839511570.USD","LU1061106388.HKD","LU1023059063.AUD","LU1585245621.USD","LU0058720904.USD","IE00B3T34201.USD","IBBQ","LU0965509101.SGD","BIB","LU1674673691.USD","BK4532","SG9999015986.USD","BBH","LU0965509283.SGD","LU1066051498.USD","LU0965509010.AUD","MEDI","LU2324357040.USD","BK4583","LU1066053197.SGD","LU1674673428.USD","SG9999015952.SGD","BK4550","LU0114720955.EUR","LU0882574055.USD","LU1037948897.HKD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623244","title":"Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623244?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","GILD","LU1934455277.USD","LU2112291526.USD","LU1066051498.USD","LU1057294990.SGD","LU1674673691.USD","IBBQ","LU0965509010.AUD","LU0889565916.HKD","BMED","SG9999015952.SGD","BK4550","BK4139","LU1934455863.HKD","LU0882574055.USD","LU0114720955.EUR","LU1585245621.USD","LU2324357040.USD","IBB","TBXU","LU0058720904.USD","LU0234570918.USD","LU0320765992.SGD","BK4566","LU1037948897.HKD","LU1430594728.SGD","BBH","TMED","LU1674673428.USD","LU0965509283.SGD","BK4588","SG9999015978.USD","LU0859254822.USD","LU1066053197.SGD","MEDI","LU1061106388.HKD","IE0002270589.USD","IE00B19Z3581.USD","BIB","SG9999015945.SGD","IE00B19Z3B42.SGD","BK4568","LU1839511570.USD","LU0289739699.SGD","LU0122379950.USD","LU0965509101.SGD","LU1037948541.HKD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462372","title":"Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462372?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:04","pubTimestamp":1789484692,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU1037948541.HKD","LU1061106388.HKD","GILD","LU0114720955.EUR","IE00B19Z3581.USD","LU0889565916.HKD","TMED","LU0109394709.USD","LU0823416689.USD","LU0122379950.USD","LU0058720904.USD","BK4139","BBH","LU1585245621.USD","LU0882574055.USD","SG9999015945.SGD","IBB","LU1430594728.SGD","LU0965509101.SGD","BK4578","BK4550","IE00BSNM7G36.USD","BK4568","LU0289739699.SGD","LU1674673691.USD","LU0965508806.USD","LU1023059063.AUD","LU1057294990.SGD","LU2357627491.SGD","IBBQ","LU1571399168.USD","LU1934455863.HKD","BMED","LU1934455277.USD","TBXU","LU0234570918.USD","MEDI","LU0965509010.AUD","BK4532","LU1934455194.USD","SG9999015978.USD","IE00B3T34201.USD","LU1674673428.USD","BIB","IE00B19Z3B42.SGD","LU2089984988.USD","LU0859254822.USD","IE00BZ1G4Q59.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623951","title":"LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623951","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623951?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:52","pubTimestamp":1789483971,"startTime":"0","endTime":"0","summary":"LIVE MARKETS-Autumn in New York: Factory expansion slows, input prices at multi-year highs - Empire StateMain US equity indexes red; Dow leads losses down ~1%Consumer Discretionary is weakest S&P 500 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N4570XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","LU0203347892.USD","BK4581","LU1121112475.USD","LU1066053197.SGD","LU0320765646.SGD","IE00BBT3K403.USD","LU0426412945.USD","LU1983299246.USD","LU0122379950.USD","IHE","LU1914381329.SGD","LU1929549753.HKD","LU2023250330.USD","LU2592432038.USD","LU2750360997.AUD","IE00BSNM7G36.USD","CTNM","LU2236285917.USD","FHLC","RXL","VHT","GDOC","LU0787776722.HKD","IE000M9KFDE8.USD","IYH","XLV","LU1989771016.USD","BK4550","LU2347655156.SGD","LU1894683348.USD","LU0114720955.EUR","JDOC","LU0964807845.USD","LU1629891620.HKD","MEDX","LU2487616109.SGD","SG9999013999.USD","LU1496350502.SGD","TRUH","IE000WAW04H5.SGD","FTXH","LU0345769128.USD","BMED","IXJ","LU2430703251.USD","IE0001KFT4U8.USD","PJP","LU0689472784.USD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628755","title":"LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628755","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628755?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:27","pubTimestamp":1789482448,"startTime":"0","endTime":"0","summary":"LIVE MARKETS-US stock indexes swing lower as oil, yields jumpMain US equity indexes red; Dow leads losses down ~1%Consumer Discretionary is weakest S&P 500 sector; energy sole gainerEuro STOXX 600 ind","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N4570WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","LU0203347892.USD","LU1221951129.SGD","LU0820562030.AUD","LU1066051811.HKD","LU2456880835.USD","LU1674673428.USD","IE00BLSP4239.USD","LU1585245621.USD","BK4592","IHE","LU0795875169.SGD","LU2417539215.USD","IE000F7OJYX1.SGD","LU2471134523.USD","LU2592432038.USD","SG9999002224.SGD","LU2471134952.CNY","IE00BVYPNV92.GBP","CTNM","LU2236285917.USD","LU2505996509.AUD","FHLC","RXL","VHT","GDOC","IE000BZT7R73.USD","XLV","IYH","LU1043141396.HKD","IE00BZ1G4Q59.USD","LU1145028129.USD","JDOC","MEDX","TRUH","LU2487616109.SGD","FTXH","LU1059921491.USD","LU0345769128.USD","SG9999001176.SGD","LU0820561818.USD","LU2112291526.USD","LU2468319806.SGD","BMED","BK4568","LU2896262040.SGD","IXJ","PJP","LU0057025933.USD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645017","title":"Johnson & Johnson Says Subcutaneous Cancer Treatment Study Shows Low Rates Across Key Events, Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645017","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645017?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:09","pubTimestamp":1789466958,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  said late Monday that early results from a phase 2b study of subcutaneous Rybrevant Faspro plus Lazcluze showed consistently low rates across key treatment-related events and discontinuation in certain non-small cell lung cancer patients.The trail covers patients with previously untreated advanced non-small cell lung cancer with common epidermal growth factor receptor mutations.At a median follow-up of 8.3 months, the majority of adverse events were grade 1 or 2, with no new safety signals, while only 8% of patients discontinued treatment due to adverse events.The study showed rash in 25% of patients, while administration-related reactions and venous thromboembolism were each reported in 3%.No patients discontinued due to administration-related reactions, while only 1% discontinued due to rash and venous thromboembolism, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IXJ","LU2089984988.USD","LU0345769128.USD","LU0820562030.AUD","LU2471134879.HKD","JDOC","FHLC","LU1261432733.SGD","LU2896262040.SGD","PJP","JNJ","LU2471134796.USD","IYH","LU1280957306.USD","LU1244550494.USD","GDOC","RXL","IE00B3T34201.USD","LU1121112475.USD","LU1732799900.SGD","LU2213496289.HKD","VHT","FTXH","LU0210536198.USD","IE00B19Z3B42.SGD","LU1894683348.USD","IHE","LU1221951129.SGD","BK4559","LU1674673428.USD","BMED","LU0640476718.USD","BK4534","LU1145028129.USD","LU0289739343.SGD","BK4585","LU2403377893.USD","SGXZ80539844.SGD","LU0162691827.USD","XLV","LU0234570918.USD","MEDX","TRUH","LU0943347566.SGD","LU1043141396.HKD","LU1718418525.SGD","BK4581","LU2347655156.SGD","IE00BJJMRZ35.SGD","LU2505996681.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSPA","BBP","TACU","MRNY","IEIH","IYH","BMED","TECB","IDNA","XLVX","LABU","PINK","LFSC","NVIB","MEDI","CDIG","PSCH","GDOC","GNMX","RSPH","IBB","TBXU","SYNB","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151952155","title":"Jiangsu Hengrui Secures Green Light for HRS-4139 Tablet Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1151952155","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151952155?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:42","pubTimestamp":1789461741,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SH: 600276) has announced that its subsidiary, Fujian Shengdi Pharmaceutical Co., Ltd., has received the Drug Clinical Trial Approval Notice from the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","LU2543165471.USD","LU1997245177.USD","LU2580892789.USD","IBBJ","LU1064131003.USD","LU2495084118.USD","BK0188","LU1969619763.USD","BK0028","LU1146622755.USD","BK1191","BMED","LU0359201612.USD","LU1255011170.USD","LU1997244956.HKD","LU1997245094.SGD","LU2097828474.EUR","LU2488822045.USD","LU2097828631.EUR","LU2097828714.EUR","BK0060","600276","LU0405327494.USD","LU0359201885.HKD","BK0012","MDTX","LU2289578879.USD","LU1328615791.USD","LU0405327148.USD","LU1820825898.SGD","LU2097828557.USD","LU2580892862.HKD","LU1781817850.SGD","IBBQ","BK0239","LU1655091616.SGD","LU2148510915.USD","PSYK","LU0359202008.SGD","LU1580142542.USD","01276","LU2328871848.SGD","LU1064130708.USD","LU2097828805.USD","LU1023057109.AUD","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165786716","title":"Huangjia Ruangan Granules Receives Approval for Phase III Clinical Trial in Chronic Hepatitis B Fibrosis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1165786716","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165786716?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:18","pubTimestamp":1789460304,"startTime":"0","endTime":"0","summary":"Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) has announced that it recently received the Drug Clinical Trial Supplemental Application Approval Notice issued by the National Medical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","IBBJ","300878","PSYK","IBBQ","BMED","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106452599","title":"Shenyang Xingqi Pharma Gains NMPA Approval to Initiate Clinical Trials for SQ-25012 Injection in Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=1106452599","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106452599?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:58","pubTimestamp":1789459095,"startTime":"0","endTime":"0","summary":"Shenyang Xingqi Pharmaceutical Co., Ltd. (300573.SZ) has announced that it recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration (NMPA)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK0177","IBBQ","IBBJ","MDTX","BK0239","BMED","300573"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}